Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I believe you to be correct!
BWMG!!!
Added today at .16.
I'm for that!
BWMG!!!
One thing we can truthfully say, is that Brownies doesn't try to pump the stock. They put out news that is pertinent, as it unfolds. The company has been around a long time and I think Robert is planning for the business to grow in a stable, low-risk manner. I believe he wants his family members that have a good amount of stock, to benefit greatly as the company grows. This movement to OTCBQ is a good move relative to demonstrating shareholder confidence regarding the future of the company. All my opinion. I picked up a few more shares today.
BWMG!!!!
BWMG is a huge bargain, IMO, even without the vents. I'm one that has been buying these bargains almost daily, in the .013 to .015 range. I'm surprised that anyone is giving up BWMG shares that cheaply.
BWMG!!!!
I feel good about the potential of BWMG and I, as well, picked up a few more shares today. Good luck to all here.
BWMG!!!
SANUWAVE Health Announces Regulatory Clearance for dermaPACE in Mexico by the Federal Commission for Protection against Sanitary Risks (COFEPRIS)
Press Release | 10/14/2020
Forms Joint Venture with MEDSTENT, S.A. to Market dermaPACE in Mexico to Treat a Variety of Chronic Wounds
SUWANEE, GA, Oct. 14, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, announced today that the Company has received regulatory clearance from the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) to market its proprietary dermaPACE® System to treat a variety of chronic wounds in Mexico, including diabetic foot ulcers (DFUs), venous and arterial ulcers, and post-traumatic and post-surgical wounds.
In addition, SANUWAVE announces the formation of a joint venture with MEDSTENT, S.A. de C.V. for the exclusive rights to market and distribute the dermaPACE® System as a treatment for chronic and acute wounds in Mexico in exchange for joint profit sharing.
"COFEPRIS clearance to market dermaPACE® in Mexico is a key achievement in our global expansion strategy and represents our second distribution agreement in the Latin America region. We look forward to working with MEDSTENT to bring our non-invasive shockwave technology to the millions of patients across Mexico who suffer with unhealing, chronic wounds. The MEDSTENT team has considerable experience and expertise in introducing and marketing innovative medical products in Mexico where more than 50% of the population has access to public healthcare. We believe that MEDSTENT’s knowledge of the Mexican market, its vascular sales teams and distribution centers will be very beneficial for successful market entry, especially to the governmental hospitals, which are the dominant healthcare provider in Mexico in general and specifically when it comes to the treatment of advanced wounds," stated Kevin A. Richardson, II, Chairman and Chief Executive Officer of SANUWAVE Health.
“Incorporating SANUWAVE’s dermaPACE® System into MEDSTENT medical products portfolio allows us to leverage our experience in the vascular surgery markets in Mexico. We are creating a wound care specialty within our vascular expertise and this joint venture with SANUWAVE provides us with a broad offering for vascular surgeons, who also treat these recalcitrant, chronic wounds,” noted Daniel Capuano, Chief Executive Officer of MEDSTENT. “We look forward to partnering with SANUWAVE and expect a successful launch of this end-to-end wound care offering in Mexico, where limited effective treatment options can often lead to lower limb amputations.”
About Chronic Wounds in Mexico
In Mexico, the compound annual growth rate (CAGR) in wound care in general is projected to be 6.72% for the next five years. The key contributors to the market growth are an increasing older population and the growing burden of chronic wounds. According to the National Council for the Evaluation of Social Development Policy 2018, approximately 7.8% of the Mexican population are aged 65 and above.1 The International Diabetes Federation data, the prevalence of diabetes among Mexican population aged between 20 and 79 years was approximately 10.8% in 2010 and significantly increased to 13.5% in 2019. Furthermore, it is well known that chronic venous disease (CVD) is a prevalent disease in the Mexican population. Up to 67.8% of Mexicans have some degree of the disease, and out of those, according to the Vein Consult Study, 2.5% of them have Stages C5 and C6, which makes them prone to develop chronic venous ulcers.2 Currently, there are no effective curative treatments for various chronic wounds being utilized in Mexico, which has led to high rates of lower limb amputations.
About the dermaPACE® System
The dermaPACE® System is a novel medical system based on shockwave technology, which has been used for nearly 30 years in lithotripsy procedures (destruction of kidney stones) and later in orthopedic treatments. These early lithotripsy and orthopedic devices provided the earliest evidence that there was an effect on wound healing. Pulsed Acoustic Cellular Expression (PACE®) Technology was developed based on this evidence, and the dermaPACE® System is the first to utilize PACE-specific proprietary protocols for wound treatment. The dermaPACE® System treatment must be administered by a healthcare professional. The dermaPACE® System is FDA cleared for the treatment of diabetic foot ulcers (DFU) and it is the first and only system based on focused electrohydraulic shockwave principle cleared by the FDA for such indication. For international markets, the dermaPACE® System is CE Marked in Europe for advanced wound care indications and in Canada carries a Health Canada Medical Device class II License. The dermaPACE® System is currently licensed or approved for advanced wound care indications in Brazil, Mexico and dozens of countries and regions around the world.
About MEDSTENT, S.A. de C.V.
MEDSTENT, headquartered in Mexico City, Mexico, is a biomedical products and service provider in the Mexican medical community. MEDSTENT achieves its commitment by supplying top quality service and products in order to build a transcending relationship “supplier-doctor-patient” as a result of the synergy between “service, products and people.” MEDSTENT has been active in the Mexican medical market since 1995 and its main directors each bring more than 40 years of experience to their roles. The company has built a strong relationship with its clients in the public and private sectors. MEDSTENT contributes to the patients’ wellbeing, health and quality of life by distributing high quality medical devices and services according to ISO 13485 and ISO 9001 driven standards as well as domestic and international regulations. The Company prides itself on the constant improvement of its quality systems, which aim to surpass our customers’ expectations.
MEDSTENT is constantly seeking for innovative technologies to serve the Mexican medical market. It is a pioneer in the Cardiovascular field and works with and offers service directly to Vascular Surgeons involved in Wound Care treatment.
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. (OTCQB:SNWV) (www.SANUWAVE.com) is focused on the research, development, and commercialization of its patented noninvasive and biological response activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. Through its recent acquisition of Celularity’s UltraMIST® assets, SANUWAVE now combines two highly complementary and market-cleared energy transfer technologies and two human tissue biologic products, which creates a platform of scale with an end-to-end product offering in the advanced wound care market.
SANUWAVE’s portfolio of regenerative medicine products and product candidates activate tissue regeneration biological signaling and angiogenic responses, producing new vascularization and microcirculatory improvement combined with tissue growth which helps restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, plastic/cosmetic and cardiac/endovascular conditions.
For additional information about the Company, visit www. www sanuwave.com.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the regulatory approval and marketing of the Company’s product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
SANUWAVE Health, Inc.
Kevin Richardson II
Chairman and Chief Executive Officer
978-922-2447
investorrelations@sanuwave.com
Anne Marie Fields
Managing Director
Rx Communications Group
afields@rxir.com
1 https://www.mordorintelligence.com/industry-reports/mexico-wound-care-management-devices-market
2 https://doi.org/10.1016/j.jvs.2019.08.143
Primary Logo
Can Investors Capitalize on Volatility?
Sponsored By: The Options Industry Council
Sign up to attend Volatility Strategies, a free webinar presented by OIC on October 14 at 3:30 PM CST. We’ll cover a variety of topics, including short straddles and long strangles, short strangles versus iron condors and much more. Read More
Back to News Headlines
Other Financial Information
Recent News & Disclosure Filings
Recent SEC Filings
OTCQB Member Since 03/2015
OTCQB
OTCQB Venture
Verified Profile 07/2020
Transfer Agent Verified
Independent Directors
Yes. See link. Check right side of page:
https://www.otcmarkets.com/stock/BWMG/overview
BWMG!!!
More credibility with this uplisting having been done. Also, I look for more exposure. These low prices, IMO, won't be here for long.
BMWG!!!
Shown here:
https://www.otcmarkets.com/stock/BWMG/overview
BWMG!!!!!
Sounds like an upgrade! Way to go BWMG!
DMDD is moving nicely today and with big volume!
That is interesting. I would think BWMG would be able to produce at a much lower cost than most and going forward, I believe we could be in play for a good amount of vent business. Also, I believe Nemo will only get bigger!
BWMG!!!
Good post. Same belief here. Adding periodically.
BWMG!!!
I haven't heard anything. I'm holding as I believe something might very well develop here. I look to add occasionally at bargain prices, which I think we're seeing now.
Check this .02 stock out. Read BWMG below:
Brownies Marine Group Gives Q2-2020 Financial and business Update
https://www.globenewswire.com/news-release/2020/09/17/2095478/0/en/Brownies-Marine-Group-Gives-Q2-2020-Financial-and-business-Update.html
September 17, 2020 15:16 ET | Source: Brownie's Marine Group, Inc.
Pompano Beach, Florida, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Brownies Marine Group, Inc. (OTC Pink: BWMG), a leading developer, manufacturer and distributor of tankless dive equipment and high pressure air and industrial compressors in the marine industry, is pleased to announce its financial results for the period ending June 30, 2020.
Selected financial highlights include:
Reported revenues for the six months ended June 30, 2020 of $1,955,317 an increase of 40.5% over the same period in 2019.
The revenue growth can be partially attributed to the rollout of our revolutionary Nemo personal tankless diving system. “We believe the BLU3 Nemo technology has initiated a revolution in the tankless dive industry, the impact and potential of this product and the subsequent design iterations from BLU3 on our Company and the industry will be substantial.“ says Robert Carmichael, CEO of BWMG.
The Q2-2020 revenue also includes revenue from the BLU3 Vent project. The company was named a Top 5 Finalist in the U.S. Department of Defense (DoD) Vulcan “Hack-a-Ventilator Challenge.” In March 2020, the DoD announced the Vulcan Hack-a-Vent Challenge to address the projected ventilator shortage as a result of the Covid-19 global pandemic. This project is currently awaiting FDA approval of an Emergency Use Authorization to put these portable ventilators, using the company’s proprietary technology, into production, if needed. Revenue related to the BLU3 Vent project was approximately 23% of overall revenue for the period.
The Company improved gross margins from 21.0% for the six months ending June 30, 2019 to 30.7% for the six months ending June 30, 2020.
Margin improvement is directly attributable to the company’s commitment to maximizing profit from each unit sold. This is being accomplished by the conversion of sales via wholesale to direct to consumer, and a restructure of the company’s dealer program to provide maximum value to both the dealers and the company.
Increased revenue and margins have improved the Company’s operating results. For the 6 months ended June 30, 2020 net income per the 10Q showed a net loss of $710,738, however, after adding back non-cash and stock based expenses this shifted to a profit after addbacks of approximately $119,000 at June 30, 2020. For the same period in 2019, the company showed a net loss of $504,351 in the 10Q and a net loss after addbacks of $310,000. Please note that net profit after addbacks is a non-GAAP calculation using the financial information from the company’s 10Q filed with the SEC for the periods ended June 30, 2020 and June 30, 2019.
Brand development with Figment Design
In June 2020 BWMG contracted Figment Design to lead its marketing campaign for the Brownies Third Lung family of products. Figment Design is Miami, FL based full-service advertising agency specializing in digital marketing where their passion is helping brands reach their true potential. The marketing effort precisely targets the ideal consumer leads them to the Company or one of the growing numbers of dealers in its network. These marketing efforts have had a positive impact on the Q2 results.
Mr. Carmichael states “the Figment Design marketing program will increase product awareness to the consumer, benefitting not only BWMG, but our dealer network as well.” Figment’s efforts and results led BLU3 to enter into a services agreement with Figment in August 2020. With BLU3, Figment will increase awareness and target buyers for the Nemo family of products.
About Brownie’s Marine Group
Brownie’s Marine Group, Inc., is the parent company to a family of innovative brands with a unique concentration in the industrial, and recreational diving industry. The Company, together with its subsidiaries, designs, tests, manufactures, and distributes recreational hookah diving, yacht-based scuba air compressors and nitrox generation systems, and scuba and water safety products in the United States and internationally. The Company has three subsidiaries: Trebor Industries, Inc., founded in 1981, dba as “Brownie’s Third Lung”; BLU3, Inc.; and Brownie’s High-Pressure Services, Inc., dba LW Americas. The Company is headquartered in Pompano Beach, Florida.
For more information, visit: www.BrowniesMarineGroup.com.
Safe Harbor Statement
This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected. Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors. Stockholders and potential investors should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements in this report are reasonable, we cannot assure stockholders and potential investors that these plans, intentions or expectations will be achieved. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 as filed with the Securities and Exchange Commission (the “SEC”) and our other periodic and quarterly filings with the SEC.
Source: Brownie’s Marine Group, Inc.
Contact Information: (954)-462-5570
investors@browniesmarinegroup.com
GO BWMG
Check this .02 stock out. Read BWMG below:
Brownies Marine Group Gives Q2-2020 Financial and business Update
https://www.globenewswire.com/news-release/2020/09/17/2095478/0/en/Brownies-Marine-Group-Gives-Q2-2020-Financial-and-business-Update.html
September 17, 2020 15:16 ET | Source: Brownie's Marine Group, Inc.
Pompano Beach, Florida, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Brownies Marine Group, Inc. (OTC Pink: BWMG), a leading developer, manufacturer and distributor of tankless dive equipment and high pressure air and industrial compressors in the marine industry, is pleased to announce its financial results for the period ending June 30, 2020.
Selected financial highlights include:
Reported revenues for the six months ended June 30, 2020 of $1,955,317 an increase of 40.5% over the same period in 2019.
The revenue growth can be partially attributed to the rollout of our revolutionary Nemo personal tankless diving system. “We believe the BLU3 Nemo technology has initiated a revolution in the tankless dive industry, the impact and potential of this product and the subsequent design iterations from BLU3 on our Company and the industry will be substantial.“ says Robert Carmichael, CEO of BWMG.
The Q2-2020 revenue also includes revenue from the BLU3 Vent project. The company was named a Top 5 Finalist in the U.S. Department of Defense (DoD) Vulcan “Hack-a-Ventilator Challenge.” In March 2020, the DoD announced the Vulcan Hack-a-Vent Challenge to address the projected ventilator shortage as a result of the Covid-19 global pandemic. This project is currently awaiting FDA approval of an Emergency Use Authorization to put these portable ventilators, using the company’s proprietary technology, into production, if needed. Revenue related to the BLU3 Vent project was approximately 23% of overall revenue for the period.
The Company improved gross margins from 21.0% for the six months ending June 30, 2019 to 30.7% for the six months ending June 30, 2020.
Margin improvement is directly attributable to the company’s commitment to maximizing profit from each unit sold. This is being accomplished by the conversion of sales via wholesale to direct to consumer, and a restructure of the company’s dealer program to provide maximum value to both the dealers and the company.
Increased revenue and margins have improved the Company’s operating results. For the 6 months ended June 30, 2020 net income per the 10Q showed a net loss of $710,738, however, after adding back non-cash and stock based expenses this shifted to a profit after addbacks of approximately $119,000 at June 30, 2020. For the same period in 2019, the company showed a net loss of $504,351 in the 10Q and a net loss after addbacks of $310,000. Please note that net profit after addbacks is a non-GAAP calculation using the financial information from the company’s 10Q filed with the SEC for the periods ended June 30, 2020 and June 30, 2019.
Brand development with Figment Design
In June 2020 BWMG contracted Figment Design to lead its marketing campaign for the Brownies Third Lung family of products. Figment Design is Miami, FL based full-service advertising agency specializing in digital marketing where their passion is helping brands reach their true potential. The marketing effort precisely targets the ideal consumer leads them to the Company or one of the growing numbers of dealers in its network. These marketing efforts have had a positive impact on the Q2 results.
Mr. Carmichael states “the Figment Design marketing program will increase product awareness to the consumer, benefitting not only BWMG, but our dealer network as well.” Figment’s efforts and results led BLU3 to enter into a services agreement with Figment in August 2020. With BLU3, Figment will increase awareness and target buyers for the Nemo family of products.
About Brownie’s Marine Group
Brownie’s Marine Group, Inc., is the parent company to a family of innovative brands with a unique concentration in the industrial, and recreational diving industry. The Company, together with its subsidiaries, designs, tests, manufactures, and distributes recreational hookah diving, yacht-based scuba air compressors and nitrox generation systems, and scuba and water safety products in the United States and internationally. The Company has three subsidiaries: Trebor Industries, Inc., founded in 1981, dba as “Brownie’s Third Lung”; BLU3, Inc.; and Brownie’s High-Pressure Services, Inc., dba LW Americas. The Company is headquartered in Pompano Beach, Florida.
For more information, visit: www.BrowniesMarineGroup.com.
Safe Harbor Statement
This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected. Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors. Stockholders and potential investors should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements in this report are reasonable, we cannot assure stockholders and potential investors that these plans, intentions or expectations will be achieved. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 as filed with the Securities and Exchange Commission (the “SEC”) and our other periodic and quarterly filings with the SEC.
Source: Brownie’s Marine Group, Inc.
Contact Information: (954)-462-5570
investors@browniesmarinegroup.com
GO BWMG
.02s gone. .021 up!
BWMG!!!!
Interest in BWMG is surely picking up. Let's have a good day, today!
BWMG!!!
Buying picked up nicely at the of the day. I suspect more tomorrow as news matriculates.
BWMG!!!
As word gets out relative to this 10Q, BWMG should start to go up. I added a little more yesterday. Company looks very promising, IMO.
BWMG!!!!
MVNT seems to be solid. Been here a while. Glad I invested.
MVNT!!!
Yes! Stock is way undervalued, IMO. Potential is huge!
BWMG!!!
Absolutely! OTC should soon read current information. Company now seems to be on the move!
BWMG!!!!
Thanks, geodan. We needed some good news! Looks like we have some, now!
BWMG!!!
Sounds good!
DMAN!!!
From Ameritrade:
September 09, 2020
2:38 pm ET
Landlords Poised to Acquire J.C. Penney Retail Business for About $800 Million, Sources Say
Dow Jones
Nice article.
SNWV!
You're reading my mind. That's where I set it yesterday, but just for part of my holdings. Missed the action today as I was on the road all day. Just now checking. Looks like we had a really good day!
SMAA!!
Stop sign has changed to Yield sign since last filing. One more filing and we should be current again.
BWMG!!!
This is what it says on the website when you click to order NEMO:
We are currently experiencing a surge in sales. New orders are expected to ship within 2-3 weeks, but we will do the best we can to ship your order ASAP!
Please have a look at our dealer map here for shops near you that might have Nemo in stock.
Bid side outnumbers ask side and is growing.
SMAA!!
Well said, and it does appears BWMG is at a bottom technically. Should go up from here, IMO.
BWMG!!!
That would be nice to get a good run. Many stocks occasionally run for no known reason. I've seen it many times. With that said, SMAA may have something coming, but the stock may run, regardless. That could get exciting.
SMAA
Yes, and the bid side is getting stronger!
SMAA!
Yes, nice to see volume.
SMAA
Nice post! Agreed! Buying opportunity now, IMO.
BWMG!!!
Encouraging. Been waiting for a long time.
SMAA
Glad to see it out!
BWMG!!!
Very true. I firmly believe BWMG should be valued at more than present pps, even without ventilators. That's why I bought more yesterday. However, I do think the financial reports need to be updated and this thing about the vent needs to be resolved. FDA could be dragging their feet, but Robert does need to update, if only on the website in the investor section.
BWMG!!!